Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion type Assertion NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_head.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion description "[The follow-up with a period of 1.2 years showed that the patients with the B+3/B0 ratios of >or= 0.3 for CEA cells or/and >or= 10 for survivin cells exhibited significantly high possibility of developed metastasis, and the sensitivity to predict developed metastasis increased from 54.5% of CEA mRNA alone to 72.7% of CEA and survivin mRNA panel.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_provenance.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion evidence source_evidence_literature NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_provenance.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion SIO_000772 18082938 NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_provenance.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion wasDerivedFrom befree-2016 NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_provenance.
- NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_assertion wasGeneratedBy ECO_0000203 NP645416.RA2UgTnCE5LiMViD7qfMRDH8yUqzVjdaj1yUyaNE1n8iQ130_provenance.